
ABSTRACT Dental caries, periodontitis, tumours, trauma and congenital defects can cause significant damage to oral tissues leading to impaired oral function and adverse systemic health effects. This review analyses the existing knowledge on biological mechanisms underlying oral wound healing and tissue regeneration, particularly focusing on the crosstalk among the oral microbiome and host immune responses. Tissue regeneration is regulated by several intracellular signalling pathways including the phosphoinositide 3‐kinase (PI3K)/protein kinase B (Akt), janus kinase and signal transducer and activator of transcription (JAK‐STAT), rat sarcoma protein (Ras)/mitogen‐activated protein kinase (MAPK), transforming growth factor‐beta (TGF‐β)/Sma and mad related protein (SMAD), wingless‐related integration site (Wnt)/beta (β)‐catenin and oxygen‐regulated signalling pathways. Collectively, these pathways coordinate epithelial migration, angiogenesis and extracellular matrix remodelling during tissue regeneration. Oral wound healing and tissue regeneration are critically impacted by the interaction between the oral microbiome and host immune mechanisms. Commensal microorganisms contribute to epithelial barrier integrity and immune regulation, whereas pathogenic species such as Streptococcus mutans , Porphyromonas gingivalis , Fusobacterium nucleatum , Treponema denticola and fungal pathogen Candida albicans can disrupt tissue repair through biofilm formation and inflammatory activation. Therapeutic strategies such as probiotics, prebiotics, synbiotics, microbiome responsive biomaterials have emerged as promising approaches to enhance craniofacial and tissue regeneration for improved healing possibilities. This review provides an integrated perspective linking oral microbial ecology, immune regulation, and intracellular regenerative signalling networks to highlight emerging microbiome‐based and biomaterial‐assisted strategies for promoting oral tissue repair and regeneration.
ABSTRACT Soft tissue defects continue to present a significant clinical challenge in plastic and reconstructive surgery. Tissue substitutes, such as dermal matrices, have been used in wound care and reconstructive practices. Specifically, foetal bovine collagen (FBC) based dermal matrices possess unique collagen profiles when compared to other scaffolds. Despite increased use in wound healing, the literature evaluating outcomes and efficacy of FBC remains insufficient. We reviewed the available evidence on FBC‐based dermal scaffolds in clinical and preclinical studies and conducted this review in accordance with PRISMA guidelines. The search strategy was developed in collaboration with our institution's medical librarians, and the final search was completed in four databases on November 20, 2025. Clinical, ex vivo and in vivo investigations published between 2006 and 2025 that evaluated FBC were eligible for inclusion. A narrative synthesis was performed due to substantial heterogeneity in outcome reporting. Of the 1132 initially identified studies, 28 met the inclusion criteria. Outcomes included wound healing, time to healing, biologic responses and physical characteristics. Overall, FBC‐based dermal matrices demonstrated regenerative potential across varying indications, with favourable wound closure outcomes relative to standard of care and untreated controls, though findings were inconsistent across comparators. Though promising data exists, heterogeneity in outcome reporting and study design limits substantiated conclusions; this prevents clinicians from making evidence‐based decisions regarding use of FBC.
ABSTRACT Tibial periosteal distraction has emerged as a potential surgical approach for ischemic diabetic foot ulcers, but evidence from large multicentre cohorts remains limited. This multicentre retrospective cohort study aimed to evaluate whether tibial periosteal distraction improves limb‐related outcomes compared with standard treatment in patients with advanced ischemic diabetic foot ulcers. Between January 2023 and June 2025, 340 patients with diabetic foot ulcers were treated at three centres. After applying predefined inclusion and exclusion criteria, 249 patients were eligible for analysis: 107 underwent tibial periosteal distraction and 142 received standard wound care and revascularization procedures. Baseline characteristics were similar between groups. Primary outcomes were ulcer healing time, major amputation, and recurrence. Computed tomography angiography and histopathology were used to evaluate vascular and tissue changes. Tibial periosteal distraction was associated with significantly shorter median healing time (26 vs. 45 days; p < 0.001), lower major amputation rate (35.5% vs. 64.8%; RR 0.55 [95% CI 0.41–0.74]; p < 0.001), and lower recurrence rate (2.8% vs. 20.4%; RR 0.14 [95% CI 0.04–0.43]; p < 0.001) compared with standard treatment. TPD significantly shortened ulcer healing time ( B = 36.485, p < 0.001) and reduced amputation risk (OR = 0.291, p < 0.001) in patients with diabetic foot ulcers. Computed tomography angiography revealed enhanced collateral formation, and histopathologic examination showed morphological changes suggestive of increased vascularity in limbs treated with tibial periosteal distraction. In this multicentre retrospective cohort, tibial periosteal distraction was associated with improved limb‐related outcomes compared with standard treatment. Prospective controlled studies are needed to confirm these findings.